Could the Artificial Sweetener Sucralose Weaken Immunotherapy?

⚠️ Why Does It Matter?

Immunotherapies are among cancer treatment's most promising recent approaches. Yet new data suggest artificial sweeteners considered harmless, such as sucralose (Splenda) , may affect treatment success. Highlighting the microbiota → arginine → T-cell axis, this study shows how small dietary habits may have major clinical consequences.

📌 Summary in 4 Points

• On July 30, 2025, Cancer Discovery published research showing that common artificial sweetener sucralose (Splenda) reduces immunotherapy efficacy in cancer patients.
• Among advanced melanoma and NSCLC patients, response rates were 27–16% with high sucralose intake versus 53–60% with low intake; PFS was also 2–3 times shorter.
• In mice, sucralose lowered arginine levels in the gut microbiota, associated with T-cell exhaustion and weakened antitumor immunity.
• Arginine or citrulline supplementation partially restored T-cell activity and immunotherapy response in mice.

What Did the Study Do?

It followed two approaches:

1. More than 150 advanced cancer patients were assessed for associations between dietary sucralose intake, immunotherapy response, and survival.
2. In tumor-bearing mice, researchers tested effects on microbiota, arginine bioavailability, and T-cell function.

📊 Clinical Findings: Effects in Numbers

Immunotherapy response and PFS in high versus low sucralose intake groups:

Note: P values indicate statistically significant differences.

Mechanism: Microbiota → Arginine → T Cell

• Microbiota effect: Sucralose exposure reduces arginine availability in the gut microbiota.
• Metabolic consequence: Lower arginine in serum and the tumor microenvironment is associated with T-cell exhaustion (loss of function).
• Functional effect: Weaker T-cell responses may undermine responses to PD-1 inhibitors .
• Reversal in mice: Arginine/citrulline supplementation partially restored T-cell activity and treatment response.

❓ What About Other Sweeteners?

• Acesulfame: Some adverse signals, but inconsistent.
• Aspartame & Saccharin: No significant effect shown (consumption levels were low).
• Earlier evidence: Sucralose and saccharin were reported to disrupt microbiota, while aspartame and stevia effects varied.

🩺 Clinical Commentary: What Should Be Done?

• A cautious approach: For patients receiving immunotherapy, sucralose and other artificial sweeteners may warrant cautious consumption .
• Dietary assessment: Diet and microbiota may influence treatment success; dietary counseling and label-reading practices should be strengthened.
• Future strategies: Microbiota-supporting pre/probiotics and dietary interventionsmay enhance immunotherapy efficacy.

🌟 Looking Ahead

Although promising, these findings need validation in large, prospective clinical studies. The message nevertheless is clear: Immunotherapy involves more than drugs; lifestyle and dietary habits are important parts of the treatment journey.